fda update on semaglutide Novo Nordisk has announced that the has approved the Wegovy® pill (once-daily oral 25 mg) as the first ever oral GLP-1 receptor agonist therapy for chronic weight management in adults FDA Approves Oral Semaglutide as
Description
The answer lies in a chain of indirect mechanisms that, when you trace them carefully, create a plausible pathway from your weekly injection to a urinary tract infection
During this phase, your digestive tract is still adjusting
This gradual increase in the dose is meant to make it easier on your body and reduce any side effects while you get used to the medicine
And timing is one of the most powerful tools you have for managing them
C.OtteS
